These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26798022)

  • 1. Vorinostat Modulates the Imbalance of T Cell Subsets, Suppresses Macrophage Activity, and Ameliorates Experimental Autoimmune Uveoretinitis.
    Fang S; Meng X; Zhang Z; Wang Y; Liu Y; You C; Yan H
    Neuromolecular Med; 2016 Mar; 18(1):134-45. PubMed ID: 26798022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate.
    Kitamei H; Iwabuchi K; Namba K; Yoshida K; Yanagawa Y; Kitaichi N; Kitamura M; Ohno S; Onoé K
    J Leukoc Biol; 2006 Jun; 79(6):1193-201. PubMed ID: 16574770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeic acid phenethyl ester lessens disease symptoms in an experimental autoimmune uveoretinitis mouse model.
    Choi JH; Roh KH; Oh H; Park SJ; Ha SM; Kang MS; Lee JH; Jung SY; Song H; Yang JW; Park S
    Exp Eye Res; 2015 May; 134():53-62. PubMed ID: 25795054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive effect of chrysin on experimental autoimmune uveitis triggered by injection of human IRBP peptide 1-20 in mice.
    Meng X; Fang S; Zhang Z; Wang Y; You C; Zhang J; Yan H
    Cell Mol Immunol; 2017 Aug; 14(8):702-711. PubMed ID: 26996065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of retinoic acid receptor-alpha/beta-specific ligand Am80 suppresses experimental autoimmune uveoretinitis.
    Keino H; Watanabe T; Sato Y; Okada AA
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1548-56. PubMed ID: 20861477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminooxy-Acetic Acid Inhibits Experimental Autoimmune Uveitis by Modulating the Balance between Effector and Regulatory Lymphocyte Subsets.
    Mei S; Huang Y; Li N; Xu Z; Xu J; Dai Q; Wu J; Kijlstra A; Yang P; Hou S
    Curr Mol Med; 2020; 20(8):624-632. PubMed ID: 32072910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide.
    Keino H; Kezuka T; Takeuchi M; Yamakawa N; Hattori T; Usui M
    Arch Ophthalmol; 2004 Aug; 122(8):1179-84. PubMed ID: 15302659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
    Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J
    Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells.
    Kohno H; Sakai T; Tsuneoka H; Imanishi K; Saito S
    Exp Eye Res; 2009 Oct; 89(4):486-93. PubMed ID: 19523946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming.
    Sartani G; Silver PB; Rizzo LV; Chan CC; Wiggert B; Mastorakos G; Caspi RR
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2211-8. PubMed ID: 8843907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
    Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
    J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
    Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
    Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
    Caspi RR; Roberge FG; Chan CC; Wiggert B; Chader GJ; Rozenszajn LA; Lando Z; Nussenblatt RB
    J Immunol; 1988 Mar; 140(5):1490-5. PubMed ID: 3346541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of liver X receptor alleviates ocular inflammation in experimental autoimmune uveitis.
    Yang H; Zheng S; Qiu Y; Yang Y; Wang C; Yang P; Li Q; Lei B
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2795-804. PubMed ID: 24699378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effect of retinoic acid on experimental autoimmune uveoretinitis.
    Keino H; Watanabe T; Sato Y; Okada AA
    Br J Ophthalmol; 2010 Jun; 94(6):802-7. PubMed ID: 19965837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
    Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
    Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12.
    Yokoi H; Kato K; Kezuka T; Sakai J; Usui M; Yagita H; Okumura K
    Eur J Immunol; 1997 Mar; 27(3):641-6. PubMed ID: 9079803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan.
    Okunuki Y; Usui Y; Nagai N; Kezuka T; Ishida S; Takeuchi M; Goto H
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2255-61. PubMed ID: 19136706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel pathogenic RBP-3 peptide reveals epitope spreading in persistent experimental autoimmune uveoretinitis.
    Boldison J; Khera TK; Copland DA; Stimpson ML; Crawford GL; Dick AD; Nicholson LB
    Immunology; 2015 Oct; 146(2):301-11. PubMed ID: 26152845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.